Moderna, Inc. (MRNA)
207.97
+9.12
(+4.59%)
USD |
NASDAQ |
Oct 27, 16:00
206.39
-1.58
(-0.76%)
After-Hours: 20:00
Moderna Cash from Operations (Quarterly) : -526.00M for June 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -526.00M |
| March 31, 2026 | -630.00M |
| December 31, 2025 | 930.00M |
| September 30, 2025 | -847.00M |
| June 30, 2025 | -919.00M |
| March 31, 2025 | -1.037B |
| December 31, 2024 | 825.00M |
| September 30, 2024 | -1.566B |
| June 30, 2024 | -1.274B |
| March 31, 2024 | -989.00M |
| December 31, 2023 | 622.00M |
| September 30, 2023 | -1.60B |
| June 30, 2023 | -915.00M |
| March 31, 2023 | -1.225B |
| December 31, 2022 | 1.662B |
| September 30, 2022 | 252.00M |
| June 30, 2022 | 304.00M |
| March 31, 2022 | 2.763B |
| Date | Value |
|---|---|
| December 31, 2021 | 3.31B |
| September 30, 2021 | 3.276B |
| June 30, 2021 | 4.063B |
| March 31, 2021 | 2.971B |
| December 31, 2020 | 1.264B |
| September 30, 2020 | 892.75M |
| June 30, 2020 | -23.88M |
| March 31, 2020 | -106.19M |
| December 31, 2019 | -98.05M |
| September 30, 2019 | -107.09M |
| June 30, 2019 | -108.58M |
| March 31, 2019 | -144.27M |
| December 31, 2018 | -91.02M |
| September 30, 2018 | -81.96M |
| June 30, 2018 | -46.50M |
| March 31, 2018 | -111.38M |
| December 31, 2017 | -102.93M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -387.32M |
| Vaxcyte, Inc. | -232.47M |
| Twist Bioscience Corp. | 1.115M |
| BioNTech SE | 12.56M |
| Vir Biotechnology, Inc. | 123.33M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 329.00M |
| Cash from Financing (Quarterly) | 14.00M |
| Free Cash Flow | -1.244B |
| Free Cash Flow Per Share (Quarterly) | -1.415 |
| Free Cash Flow to Equity (Quarterly) | -552.00M |
| Free Cash Flow to Firm (Quarterly) | -545.67M |
| Free Cash Flow Yield | -1.52% |